22 Oct 2021
This wide array of applications are anticipated to bolster prospects for the global high performance liquid chromatography market during the forecast period (2020-2026). Anticipated CAGR during this period is pegged at 5.4%. High Performance Liquid Chromatography (HPLC) is a highly sophisticated and an expensive technique, used to separate and identify various compounds in liquids and tissues.
HPLC techniques have been widely used in food processing, clinical diagnosis and forensic sciences. The technique is commonly used for drug analysis, separation of molecules and environmental control. The recent COVID-19 pandemic is poised to moderately impact testing volumes due to a number of the key companies’ employees practicing social distancing. Nevertheless, overall growth prospects shall remain positive.
“The global HPLC market is poised to expand on a positive growth trajectory in the future. The wide range of applications of HPLC techniques has prompted key players to invest heavily in strengthening their product portfolios to offer novel solutions. While the COVID-19 pandemic may limit the volumes of testing, the overall growth trend is poised to remain elevated,” interprets a Fact.MR analyst.
The global HPLC market comprises of the following players: Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, GE Healthcare, Shimadzu Corporation, PerkinElmer Inc., Gilson, Inc., and Phenomax, Inc., to name a few. These companies have invested in strengthening their product portfolio and research and development operations.
Waters Corporation is a leading life sciences company which designs, develops and markets liquid chromatography instruments, such as the Alliance HPLC System which provides advanced solvent delivery capabilities. Similarly, Agilent Technologies specializes in three categories of HPLC systems: Analytical, Application-Specific and Preparative Systems.
The leading players in the HPLC market consider the well-being of their staff of primary importance. Most players like Agilent Technologies have established business continuity plans (BCPs) to ensure that their production does not fall behind. The BCPs cover the physical infrastructure of the site, supply-chain disruptions and logistics.
The company has a diversified supply chain which helps guarantee surety of supply. While most of the workforce operates from home, there are a few workers who have to work on-site. For them, additional precautionary measures are being taken by leading players such as increased cleaning and disinfection, screening and restricted access for visitors and availability of personal protective equipment.
The research study on the global high performance liquid chromatography (HPLC) market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global blood transfusion diagnostics market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Product Type (Instruments, Consumables and Accessories) and End-user (Pharmaceutical & Biotechnology Industries, Diagnostic Laboratories, Food & Beverage Industry, Academic and Research Institutes and Others) across five major regions.
Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.
High Performance Liquid Chromatography (HPLC) Market
Free SampleAbout Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. We are known for our syndicated research, custom research, and consulting solutions.